Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Pirillo

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Current Opinion in Lipidology|July 12, 2011
Therapy and clinical trials: aggressive statin therapy versus combined and emerging approachesAlberico L Catapano, Giuseppe D Norata, Angela Pirillo
British Journal of Pharmacology|April 4, 2017
Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trialsAlberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Current Medicinal Chemistry|June 1, 2018
Biological Consequences of Dysfunctional HDLAngela Pirillo, Alberico Luigi Catapano, Giuseppe Danilo Norata
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2017
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Vascular Health and Risk Management|September 19, 2017
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectivesAlberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Biochimica Et Biophysica Acta|May 2, 2006
15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophagesAngela Pirillo, Patrizia Uboldi, Hartmut Kuhn, et al.
Pharmacological Research|January 19, 2023
Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanismsElena Osto, Fabrizia Bonacina, Angela Pirillo, et al.
Atherosclerosis|October 2, 2018
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN studyManuela Casula, Elena Olmastroni, Angela Pirillo, et al.
Atherosclerosis. Supplements|February 16, 2021
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular riskLale Tokgözoğlu, Manuela Casula, Angela Pirillo, et al.
Trends in Pharmacological Sciences|October 6, 2015
Apolipoprotein C-III: From Pathophysiology to PharmacologyGiuseppe Danilo Norata, Sotirios Tsimikas, Angela Pirillo, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Current Opinion in Lipidology|July 12, 2011
Therapy and clinical trials: aggressive statin therapy versus combined and emerging approachesAlberico L Catapano, Giuseppe D Norata, Angela Pirillo
British Journal of Pharmacology|April 4, 2017
Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trialsAlberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Current Medicinal Chemistry|June 1, 2018
Biological Consequences of Dysfunctional HDLAngela Pirillo, Alberico Luigi Catapano, Giuseppe Danilo Norata
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2017
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Vascular Health and Risk Management|September 19, 2017
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectivesAlberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Biochimica Et Biophysica Acta|May 2, 2006
15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophagesAngela Pirillo, Patrizia Uboldi, Hartmut Kuhn, et al.
Pharmacological Research|January 19, 2023
Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanismsElena Osto, Fabrizia Bonacina, Angela Pirillo, et al.
Atherosclerosis|October 2, 2018
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN studyManuela Casula, Elena Olmastroni, Angela Pirillo, et al.
Atherosclerosis. Supplements|February 16, 2021
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular riskLale Tokgözoğlu, Manuela Casula, Angela Pirillo, et al.
Trends in Pharmacological Sciences|October 6, 2015
Apolipoprotein C-III: From Pathophysiology to PharmacologyGiuseppe Danilo Norata, Sotirios Tsimikas, Angela Pirillo, et al.
Pageof 12